Goswami, Sangeeta http://orcid.org/0000-0001-9201-4503
Raychaudhuri, Deblina
Singh, Pratishtha
Natarajan, Seanu Meena
Chen, Yulong
Poon, Candice
Hennessey, Mercedes
Tannir, Aminah J.
Zhang, Jan
Anandhan, Swetha http://orcid.org/0000-0001-9187-7921
Kerrigan, Brittany Parker
Macaluso, Marc D.
He, Zhong
Jindal, Sonali http://orcid.org/0000-0002-3911-6815
Lang, Frederick F. http://orcid.org/0000-0003-3747-873X
Basu, Sreyashi http://orcid.org/0000-0002-5028-3833
Sharma, Padmanee http://orcid.org/0000-0003-4658-055X
Article History
Received: 3 February 2023
Accepted: 21 July 2023
First Online: 31 August 2023
Competing interests
: P. Sharma reports consulting, advisory roles and/or stocks/ownership for Achelois, Apricity Health, BioAlta, Codiak BioSciences, Constellation, Dragonfly Therapeutics, Forty-Seven, Inc., Hummingbird, ImaginAb, Jounce Therapeutics, Lava Therapeutics, Lytix Biopharma, Marker Therapeutics, BioNTx, Oncolytics, Glympse, Infinity Pharma and Polaris; and owns a patent licensed to Jounce Therapeutics. The remaining authors declare no competing interests.